Effects of thiazolidinediones on cardiovascular risk factors

Compr Ther. 2002 Winter;28(4):200-6. doi: 10.1007/s12019-002-0018-8.

Abstract

The thiazolidinediones are the insulin sensitizers used in the management of Type 2 diabetes mellitus. These drugs can potentially decrease the risk of cardiovascular disease by correcting the different components of the insulin resistance syndrome.

Publication types

  • Review

MeSH terms

  • Arteriosclerosis / complications
  • Arteriosclerosis / drug therapy
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Fibrinolysis / physiology
  • Humans
  • Hyperlipidemias / complications
  • Hyperlipidemias / drug therapy
  • Hypertension / complications
  • Hypertension / drug therapy
  • Hypoglycemic Agents / pharmacology*
  • Insulin Resistance / physiology
  • Risk Factors
  • Thiazoles / pharmacology*
  • Vascular Resistance / drug effects
  • Weight Gain / drug effects

Substances

  • Hypoglycemic Agents
  • Thiazoles